Skip to main content

Advertisement

SpringerLink
Log in

Does deflux alter the paradigm for the management of children with vesicoureteral reflux?

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

The recent approval by the US Food and Drug Administration of Deflux (Q Med, Uppsala, Sweden), a particulate biodegradable polymer of dextran, has led to an understandable enthusiasm for treating children with vesicoureteral reflux by a routinely simple outpatient endoscopic procedure. However, Deflux is but one of a variety of particulate substances, both permanent and absorbable, that have been used to treat reflux in Europe for well over a decade with varying degrees of success. The purpose of this review is to place Deflux in this wider context to anticipate what can be expected realistically regarding the efficacy and potential hazards of this seductive technique and to make recommendations regarding its incorporation, in selected cases, in our therapeutic armamenftarium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Matouschek E: Die Behandlung des vesikorenalen refluxes durch transurethrale Einspritzung von Teflonpaste. Urologe A 1981, 20:263–264.

    PubMed  CAS  Google Scholar 

  2. O’Donnell B, Puri P: Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J 1984, 289:7–9.

    Article  CAS  Google Scholar 

  3. Lackgren G, Wahlin N, Stenberg A: Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr Suppl 1999, 88:62–71.

    Article  PubMed  CAS  Google Scholar 

  4. Kirsch A, Perez-Brayfield M, Scherz H: Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: The Children’s Hospitals of Atlanta experience. J Urol 2003, 170:211–215. Very thorough review.

    Article  PubMed  Google Scholar 

  5. Boedts D, Roels H, Kluyskens P: Laryngeal tissue responses to Teflon. Arch Otolaryngol 1967, 86:562–567.

    PubMed  CAS  Google Scholar 

  6. Kaufman M, Lockhart JL, Silverstein MJ, Politano VA: Transurethral polytetrafluoroethylene injection for postprostatectomy incontinence. J Urol 1984, 132:463–464.

    PubMed  CAS  Google Scholar 

  7. Mittleman RE, Marraccini JV: Pulmonary Teflon granulomas following periurethral Teflon injection for urinary incontinence. Arch Pathol Lab Med 1983, 107:611–612.

    PubMed  CAS  Google Scholar 

  8. Claes H, Stroobants D, Meerbeek JV, et al.: Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 1989, 142:821–822.

    PubMed  CAS  Google Scholar 

  9. Schulman CC, Simon J, Pamart D, Avni FE: Endoscopic treatment of vesicoureteral reflux in children. J Urol 1987, 138:950–952.

    PubMed  CAS  Google Scholar 

  10. Malizia AA, Reiman HM, Myers RP, et al.: Migration and granulomatous reaction after periurethral injection of Polytef (Teflon). J Am Med Ass 1984, 251:3277–3281.

    Article  Google Scholar 

  11. Aaronson IA, Rames RA, Greene WB, et al.: Endoscopic treatment of reflux: migration of Teflon to the lungs and brain. Eur Urol 1993, 23:394–399.

    PubMed  CAS  Google Scholar 

  12. Schulman CC: Macroplastique: a new uro-implant for the endoscopic correction of reflux [Abstract]. Presented at the Second International Congress of Endoscopic Paediatric Urology. Switzerland: October 8–9, 1993.

  13. Henly DR, Barratt DM, Weiland TL, et al.: Particulate silicone for use in periurethral injection: a study of local tissue effects and a search for migration [Abstract]. J Urol 1992, 147:376a.

    Google Scholar 

  14. Stenberg AM, Sundin A, Larsson BS, et al.: Lack of distant migration after injection of a 125iodine-labeled dextranomer-based implant into the rabbit bladder. J Urol 1997, 158:1937–1941.

    Article  PubMed  CAS  Google Scholar 

  15. Burns MW, Mitchell ME: Why we’ve abandoned Polytef injection for VUR. Contemp Urol 1991, 3:40–43.

    PubMed  CAS  Google Scholar 

  16. Sauvage P, Geiss S, Dhaoui R, et al.: Analysis and technical refinements of endoscopic treatment of vesicoureteral reflux in children with a 40-month follow-up. Pediatr Surg Int 1991, 6:277–280.

    Article  Google Scholar 

  17. Stenberg A, Larsson E, Lackgren G: Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 2003, 169:1109–1113.

    Article  PubMed  CAS  Google Scholar 

  18. Silver RM, Sahn EE, Allen JA, et al.: Demonstration of silicon in sites of connective-tissue disease in patients with siliconegel breast implants. Arch Dermatol 1993, 129:63–68.

    Article  PubMed  CAS  Google Scholar 

  19. Barrett DM, O’Sullivan DC, Malizia AA, et al.: Particle shedding and migration from silicone genitorurinary prosthetic devices. J Urol 1991, 146:319–322.

    PubMed  CAS  Google Scholar 

  20. Reinberg Y, Manivel JC, Gonzalez R: Silicone shedding from artificial urinary sphincter in children. J Urol 1993, 150:694–696.

    PubMed  CAS  Google Scholar 

  21. Puri P, Chertin B, Velayudham M, et al.: Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/ hyaluronic acid copolymer: preliminary results. J Urol 2003, 170:1541–1544.

    Article  PubMed  CAS  Google Scholar 

  22. Puri P: The present status of the sting [Abstract]. Presented at the Second International Congress of Endoscopic Paediatric Urology. Switzerland: October 8–9, 1993.

  23. Geiss S, Alessandrini P, Allouch G, et al.: Multi-center survey of endoscopic treatment of vesicoureteral reflux in children. Eur Urol 1990, 17:328–329.

    PubMed  CAS  Google Scholar 

  24. Puri P: Endoscopic correction of primary vesicoureteric reflux by subureteric Teflon injection (Sting): follow-up study in 123 patients. Pediatr Surg Int 1991, 6:269–272.

    Article  Google Scholar 

  25. Dodat H, Takvorian P, Sabatier E, et al.: Treatment of vesicoureteral reflux in children by endoscopic injection of Teflon. Pediatr Surg Int 1991, 6:273–276.

    Article  Google Scholar 

  26. Frey P, Berger D, Jenny P, Herzog B: Subureteral collagen injection for the endoscopic treatment of vesicoureteral reflux in children: follow-up study of 97 treated ureters and histological analysis of collagen implants. J Urol 1992, 148:718–723.

    PubMed  CAS  Google Scholar 

  27. Leonard M, Canning D, Peters C, et al.: Endoscopic injection of glutaraldehyde cross-linked bovine dermal collagen for correction of vesicoureteral reflux. J Urol 1991, 145:115–119.

    PubMed  CAS  Google Scholar 

  28. Frey P, Berger D, Herzog B, Jenny P: SCIN remains an excellent method of treatment of vesicoureteric reflux in children in selected cases [Abstract]. Presented at the Second International Congress of Endoscopic Paediatric Urology. Switzerland: October 8–9, 1993.

  29. Stenberg A, Lackgren G: A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and shortterm clinical results. J Urol 1995, 154:800–803.

    Article  PubMed  CAS  Google Scholar 

  30. Lackgren G, Wahlin N, Skoldenberg E, et al.: Long-term follow-up of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2001, 166:1887–1892.

    Article  PubMed  CAS  Google Scholar 

  31. Perez-Brayfield M, Kirsch A, Hensle T, et al.: Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 2004, 172:1614–1616. Excellent review of dextranomer/hyaluronic acid.

    Article  PubMed  CAS  Google Scholar 

  32. Capozza N, De Gennaro M, Mosiello G, et al.: Sub ureteral collagen injection (SCIN): when it fails and why [Abstract]. Presented at the Second International Congress of Endoscopic Paediatric Urology. Switzerland: October 8–9, 1993.

  33. Diamond D, Caldamone A, Bauer S, et al.: Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy. J Urol 2003, 170:1556–1559.

    Article  PubMed  Google Scholar 

  34. Kobelt G, Canning D, Hensle T, et al.: The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2003, 169:1480–1485.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical University of South Carolina, Clinical Science Building, 96 Jonathan Lucas Street, Room 644, P.O. Box 250620, 29425, Charleston, SC, USA

    Ian A. Aaronson MD

Authors
  1. Ian A. Aaronson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aaronson, I.A. Does deflux alter the paradigm for the management of children with vesicoureteral reflux?. Curr Urol Rep 6, 152–156 (2005). https://doi.org/10.1007/s11934-005-0085-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-005-0085-3

Keywords

Search

Navigation